Alloy Therapeutics
A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.
About
Alloy Therapeutics is a biotechnology ecosystem company focused on accelerating drug discovery and development. They leverage AI-driven platforms and integrated services to support the entire process, evolving from an antibody discovery pioneer to a full-stack biotech infrastructure provider. Their offerings aim to streamline and enhance the efficiency of bringing new therapeutics to market. Teams look it up for Biotechnology, Artificial Intelligence, Drug Discovery.
Frequently asked
What does Alloy Therapeutics do?
Alloy Therapeutics is a Biotechnology company that offers Platform. Teams look it up for Artificial Intelligence, Drug Discovery, Drug Development. It is based in Boston, Massachusetts, USA and was founded in 2017. Public records show $157M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Alloy Therapeutics raised?
Alloy Therapeutics has raised a total of $157M in funding. The most recent round on record is Series E.
Where is Alloy Therapeutics headquartered?
Alloy Therapeutics is headquartered in Boston, Massachusetts, USA.
When was Alloy Therapeutics founded?
Alloy Therapeutics was founded in 2017.
What industry does Alloy Therapeutics operate in?
Alloy Therapeutics operates in Biotechnology, Artificial Intelligence, Drug Discovery, Drug Development, Biotech.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.